Skye Bioscience (SKYE) Accounts Payables (2012 - 2026)
Skye Bioscience's Accounts Payables was $4.28 million in Q2 2026, up 32.8% from $3.22 million a year earlier and up 8.7% from the prior quarter.
Powered by 
Analysis
Skye Bioscience (SKYE) Accounts Payables (2012 - 2026) Analysis & Trends
At the end of FY2025, Accounts Payables at Skye Bioscience came in at $2.03 million, up 257.2% from FY2024.
- Accounts Payables shows a five-year compound annual growth rate of 41.0% (FY2020 to FY2025).
- In earlier years, Accounts Payables was $569,252 in FY2024 (-50.7%), $1.16 million in FY2023 (-30.8%), $1.67 million in FY2022 (+86.0%) and $897,880 in FY2021 (+146.4%).
- The Q2 2026 figure marks the highest quarterly Accounts Payables in data going back to Q4 2012.
- Compared with a year earlier, Accounts Payables has increased for six straight quarters, with growth averaging 104.2% over the last eight quarters.
- The best year-over-year quarter for Accounts Payables over five years was Q3 2022 (growth of 548.2%); the worst was Q3 2021 (a decline of 56.4%).
- Per Business Quant data, SKYE's Accounts Payables in the three quarters before Q2 2026 was $3.94 million (Q1 2026), $2.03 million (Q4 2025) and $2.83 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 9.22 Bn |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 33.30 Bn |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | 3.83 Bn |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | 4.26 Bn |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | -22.89 Bn |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 2.87 Bn |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | 674.00 Mn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 4.58 Bn |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 429.50 Mn |
| 10 | Skye Bioscience | 6.98 Mn | 6.98 Mn | - | 4.28 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 4.28 Mn |
| Mar 31, 2026 | 3.94 Mn |
| Dec 31, 2025 | 2.03 Mn |
| Sep 30, 2025 | 2.83 Mn |
| Jun 30, 2025 | 3.22 Mn |
| Mar 31, 2025 | 1.71 Mn |
| Dec 31, 2024 | 569,252.00 |
| Sep 30, 2024 | 780,025.00 |
| Jun 30, 2024 | 1.08 Mn |
| Mar 31, 2024 | 1.10 Mn |
| Dec 31, 2023 | 1.16 Mn |
| Sep 30, 2023 | 1.63 Mn |
| Jun 30, 2023 | 1.55 Mn |
| Mar 31, 2023 | 1.22 Mn |
| Dec 31, 2022 | 1.67 Mn |
| Sep 30, 2022 | 2.07 Mn |
| Jun 30, 2022 | 1.44 Mn |
| Mar 31, 2022 | 878,720.00 |
| Dec 31, 2021 | 897,880.00 |
| Sep 30, 2021 | 318,982.00 |
API Access
Skye Bioscience Accounts Payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=accounts-payables&ticker=SKYE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "accounts-payables", "ticker": "SKYE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=accounts-payables&ticker=SKYE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();